|
Market Closed -
Euronext Paris
19:55:00 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.8620 EUR | -2.60% |
|
+7.48% | -10.21% |
| 09-03 | Transgene jumps 20% on positive cancer vaccine data in early trial | RE |
| 09-02 | Transgene: no cases of recurrence at three years among patients treated with TG4050 |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TRANSGENE | Bio Therapeutic Drugs | -2.60% | +7.48% | -10.21% | -21.99% | -67.90% | 274M |  | |  |
- Stock Market
- Stocks
- TNG Stock
- Charts Transgene
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
